Page last updated: 2024-09-04

canertinib dihydrochloride and su 14813

canertinib dihydrochloride has been researched along with su 14813 in 1 studies

Compound Research Comparison

Studies
(canertinib dihydrochloride)
Trials
(canertinib dihydrochloride)
Recent Studies (post-2010)
(canertinib dihydrochloride)
Studies
(su 14813)
Trials
(su 14813)
Recent Studies (post-2010) (su 14813)
311361319

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Russu, WA; Shallal, HM1

Other Studies

1 other study(ies) available for canertinib dihydrochloride and su 14813

ArticleYear
Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:6

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Piperazines; Protein Kinase Inhibitors; Protein Kinases; Pyrimidines; Stereoisomerism; Structure-Activity Relationship

2011